Related Experiment Video
Updated: Mar 7, 2026

In Vivo Real-Time Study of Drug Effects on Carotid Blood Flow in the Ovine Fetus
Published on: April 28, 2023
The effect of maternal low flow oxygen administration during the second stage of labour on umbilical cord artery pH:
1Department of Obstetrics and Gynaecology, Navy General Hospital, Beijing, China.
Objective:
To assess the effect of maternal low flow oxygen administration during the second stage of labour on umbilical cord artery pH.
Design:
A randomised controlled trial.
Setting:
A tertiary teaching hospital in China.
Population:
Women in the second stage of labour with no complications.
Methods:
About 443 women were randomly allocated to receive either supplemental oxygen at a flow rate of 2 l/min or a sham supplementation by nasal cannula. Healthcare providers, women and outcome assessors were blinded to allocation.
Main Outcome Measures:
Umbilical cord artery pH and fetal heart rate (FHR) pattern.
Results:
Baseline characteristics were similar between the two groups. There were no significant differences between the two groups in the umbilical cord artery pH [median 7.261, interquartile range (IQR) 7.228-7.295 versus 7.266 (IQR 7.232-7.297), P = 0.64], the proportion with pH less than 7.2 [30/219 versus 34/224, P = 0.66, RR (relative risk) 0.9, 95% CI 0.57-1.42], and the proportion with normal FHR pattern (147/219 versus 153/224, P = 0.79, RR 0.98, 95% CI 0.86-1.12). Maternal partial pressure of dissolved oxygen was significantly higher in the oxygen group than in the sham group [median 150.0 mmHg (IQR 142.6-156.7) versus 112.0 (IQR 104.8-118.3), P < 0.001], whereas carbon dioxide was significantly lower in the oxygen group than in the sham group (mean difference -1.1, 95% CI -2.1 to -0.1, P = 0.03).
Conclusion:
The use of 2 l/min maternal oxygen during the second stage of labour did not adversely affect either the umbilical artery pH or the FHR pattern distribution.
Tweetable Abstract:
No difference in abnormal fetal acid base or normal heart rate if maternal O2 given, randomised trial finds.

